excluded. However, we considered publications that excluded cystic nodules or nodules smaller than the defined diameter.
Statistical analysis
We meta-analyzed odds ratios (ORs) and risk ratios (RRs) using a random--effects model using the Statistica v.10 software with medical package. T 2 and i 2 values given in the "Results" section are based on OR calculations. Pooled sensitivities, specificities, positive and negative predictive values (PPV and NPV) of particular markers of malignancy were calculated using a random-effects model according to the methodology described by Borenstein et al.
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RESULTS Fourteen studies met the inclusion criteria and were subjected to a meta-analysis (TABLE 1) . These studies encompassed 5439 thyroid lesions -4712 benign nodules and 727 cancers. The steps of selection are presented in FIGURE 1.
Microcalcifications Thirteen studies provided data on the frequency of microcalcifications, amounting to 5308 nodules (718 malignant, 13.5%). The pooled OR equaled 7.1 (95% confidence interval [CI], 4.3-11.9); RR, 3.8 (95% CI, 3.0-5.0); sensitivity, 44.1% (95% CI, 37.9%-51.3%); specificity, 75.9% (95% CI, 70.3%-82.0%). PPV was 42.3% (95% CI, 33.6%-53.3%) and NPV was 88.6% (95% CI,
MATERIALS AND METHODS Data extraction and selection criteria
We searched the PubMed/ MEDLINE and Cochrane Library databases to identify all relevant research papers. Search terms included: (thyroid cancer OR thyroid nodules) and (ultrasound OR ultrasonography OR elastography OR "power doppler" or "colour doppler"). The following filters were applied: English language as well as publication date between January 2007 and February 2013. The literature search was performed independently by 2 authors (K.W. and M.S.).
Only the prospective studies conducted not earlier than in 2002 and performed with the use of a transducer with the frequency of at least 7.5 MHz were included in the meta-analysis. The aim of those limitations was to avoid underestimation of the diagnostic value of ultrasound markers of malignancy, which might have occurred if older studies, performed with lower--quality equipment, had been included. We also excluded studies in which the diagnosis of malignant, or suspicious, nodules was based only on cytopathology, without subsequent histopathological examination and differentiation between malignant and benign nodules.
Studies focusing only on particular subgroups of patients (e.g., surgical or pediatric patients only) or particular types of nodules (e.g., subcentimeter, palpable, pure cystic or mixed, etc.) were . There was no evidence of significant heterogeneity (Q = 2.4; df = 2; P = 0.30; i 2 = 17.3%) or publication bias (Kendell's tau, 0.33; 2-tailed P value, 0.60).
Halo absence Four studies provided data on the halo absence frequency, amounting to 648 nodules (112 malignant, 17.2%). The pooled OR was 3.8 (95% CI, 1.7-8.5); RR, 3.0 (95% CI, 1.5-6.0); sensitivity, 63.8% (95% CI, 38.1-100.0); specificity, 47.5% (95% CI, 33.4-67.8). PPV was 23.5% (95% CI, 15.6-35.6) and NPV was 91.3% (95% CI, 60.0-100.0). There was no evidence of significant heterogeneity (Q = 3.4; df = 3; P = 0.33; i 2 = 10.7%) or publication bias (Kendell's tau, -0.33; 2-tailed P value, 0.50).
Color Doppler examination Three studies provided data on the frequency of intranodular flow in color Doppler examination, including 1048 nodules (214 malignant, 20.4%). The pooled OR was 4.3 (95% CI, 3.1-6.1); RR, 2.6 (95% CI, 1.6 -4.0); sensitivity, 44.2% (95% CI, 33.6-58.2); specificity, 81.5% (95% CI, 67.8-98.0); PPV, 41.3% (95% CI, 28.4-60.2); NPV, 82.4% (95% CI, 67.6-100.0). There was no evidence of significant heterogeneity (Q = 1.8; df = 2; P = 0.41; i 2 = 0.0%) or publication bias (Kendell's tau with continuity correction, 0.0; 2-tailed P value, 1.0). Hypoechogenicity Eleven of the 14 selected studies provided data on the frequency of hypoechogenicity, adding up to 5179 nodules (682 malignant, 13.2%). The pooled OR was 3.2 (95% CI, 2.3-4.5); RR, 2.5 (2.0-3.1); sensitivity, 68.7% (95% CI, 58.8%-82.6%); specificity, 60.3% (95% CI, 53.4%-68.2%). PPV was 25.2% (95% CI, 17.6%-36.2%), NPV was 91.4% (95% CI, 78.8%-100.0%). There was no evidence of significant heterogeneity (Q = 16.7; df = 10; P = 0.08; i 2 = 39.9%), or publication bias (Kendall's tau, 0.35; 2-tailed P value, 0.14).
Irregular margins Thirteen studies provided data on the frequency of irregular margins, including a total of 5296 nodules (707 malignant, 13.3%). The pooled OR was 7.2 (95% CI, 4.5-11.5); RR, 4.1 (95% CI, 3.1-5.5); sensitivity, 45.5% (95% CI, 30.9%-66.9%); specificity, 79.6% (95% CI, 71.9%-88.2%). PPV was 40.4% (95% CI, 29.9%-54.7%) and NPV was 88.9% (95% CI, 80.4%-98.3%). There was no evidence of significant heterogeneity (Q = 12.9; df = 12; P = 0.38; i 2 = 7.1%) or publication bias (Kendall's tau, 0.03; 2-tailed P, 0.90).
Elastography Ten studies provided data on lesion stiffness graded according to elastography of RRs for the features present. With the assumption that particular markers are independent variables, the highest obtained value would indicate the nodule presenting the highest risk of malignancy.
DISCUSSION
The fourteen studies included in the meta-analyisis contain data on 4479 patients with 5439 thyroid nodules that were subject to FNAB (and eventually postsurgical histopathology). Of all nodules, 727 turned out to be cancers (13.4%). The smallest malignancy ratio was 9.4% 10,15 and the highest -32.1%. 19 This ratio was somewhat higher than expected. It might have to the taller-than-wide shape, they showed rather poor sensitivity and slightly better specificity. On the other hand, hypoechogenicity and absent halo were slightly but significantly more common in thyroid cancers than in benign nodules with poor specificity.
Pattern 3 flow on power Doppler ultrasound turned out to be more frequent in thyroid cancers, but this result was statistically insignificant. Intranodular blood flow on color Doppler ultrasound seemed to be more reliable and statistically significant. However, sensitivity of this been partially caused by the fact that most studies excluded certain groups of nodules (e.g., pure cystic) with the expected low malignancy rate. Additionally, we cannot exclude the possibility that, in some studies, patients with nodules characterized by suspicious appearance on ultrasound were preferentially included.
The taller-than-wide shape turned out to be the strongest predictor of malignant thyroid nodules; however, its sensitivity was low. Microcalcifications and irregular margins were also suspicious findings suggestive of malignancy, but similarly Another approach to improve diagnostic accuracy is to combine classic ultrasound markers of malignancy. In the simplest version, this would mean to assess several markers together, and, in a more advanced form, to evaluate the risk (including information about all ultrasound markers) and to find out how it affects the a priori malignancy risk with the use of, for example, the Bayesian network.
Of note, most cancers assessed in the studies included in our meta -analysis were papillary thyroid carcinomas. In those studies which provided the exact information on the final histopathological results, about 89% of cancers on average were papillary thyroid carcinomas. Therefore, the above ultrasound markers of malignancy might not be similarly reliable in the case of other thyroid carcinomas. A study on follicular carcinomas revealed that certain classic predictors of malignancy were frequent in this group (e.g., hypoechogenicity, 82%; halo absent, 64%), while others were rare (e.g., calcifications, 14%). 25 The few available studies on medullary thyroid cancer report rather divergent results; yet, they indicate that this subgroup of thyroid cancers might present a relatively benign appearance on ultrasound. 26,27 To sum up, data on ultrasound features of nonpapillary thyroid cancer are limited.
Many ultrasound features seem to be valuable markers of malignancy. However, it is worth noting that although the results of individual studies usually demonstrate the same trend, the estimation of the effect size (e.g., OR) is widely varied. For instance, among 13 studies assessing the regularity of nodule margins, the lowest reported OR was 1.8, while the highest was 39.9. 95% CIs are wide (OR, 4.5-11.5). Similarly, the results referring to pattern 3 in power Doppler examination varied significantly. 24 Only in 6 studies, OR was between 0.8 and 50.4, 95% CI of the pooled result was also wide (0.8-8.3); nevertheless, it may partially be a consequence of a small number of studies. The taller-thanwide shape is a strong marker of malignancy (OR, 13.7; 95% CI, 4.1-45.7). However, the sensitivity (25.9% with 95% CI, 12.1%-55.3%) and specificity (95.9%, 95% CI, 48.3-100.0) are, in fact, difficult to determine.
According to our results, many ultrasound features are valuable markers of malignancy and should not be omitted when interpreting ultrasound results. Although the Society of Radiologists in Ultrasound recommends mainly calcifications and solid or predominantly solid composition as features prompting biopsy, 28 our meta--analysis reveals that other ultrasound features, such as the taller-than-wide shape or irregular margins, are also strong predictors of malignancy. marker was unsatisfactory. According to the available data, decreased elasticity of a lesion was also a potent predictor of malignant thyroid nodules, with the second highest OR (after the taller-thanwide shape). This finding is in line with the results of our previous study including patients referred for thyroid surgery, which indicated a very high diagnostic value of shear-wave elastography (OR of up to 54.5 depending on the threshold). 24 Although we did not have enough data to meta--analyze the average size of both malignant and benign nodules, the available results are interesting. According to Rossi et al., 12 144 of 233 malignant nodules (61.8%) were smaller than 1 cm in the maximum diameter, while in the report by Azizi et al., 10 this was observed in 39 of 86 cancers (45.3%). In this context, leaving subcentimeter nodules without undertaking further diagnostic measures might have led to misdiagnosis and treatment delay in a considerable number of cancers. There was also not enough information to meta-analyze the presence of macrocalcifications. However, the available data suggest a rather low diagnostic value of this parameter. According to Azizi et al., 10 macrocalcifications were insignificantly more prevalent in cancers (OR, 1.6; 95% CI, 0.7-3.6), while in the study performed by D'Souza et al., 17 they occurred slightly less frequently in malignancies (OR, 0.12; 95% CI, 0.02-1.02). The data on nodule composition were also insufficient to perform a meta-analysis. Nevertheless, the available statistics are divergent. In the study performed by Bhatia et al.,
14 all 19 thyroid cancers and 5 metastases from other organs were solid, while 53% of benign nodules were partially cystic. According to Azizi et al.,
10 solid nodules had a statistically insignificantly increased risk of malignancy (73.3% of malignant and 66.0% of benign nodules were solid; OR, 1.4; 95% CI, 0.9-2.3). D'Souza et al. 17 reported similar results (65.4% of cancers and 59.2% of benign nodules were solid; OR, 1.3; 95% CI, 0.5-3.1). However, unlike cancers, 10.3% of benign lesions were purely cystic.
There were also some new ultrasound markers that could not be meta-analyzed owing to an insufficient number of studies but should be considered in future research. Azizi et al. 10 distinguished To conclude, certain ultrasound characteristics of thyroid nodules seem to be valuable for the preliminary assessment of thyroid nodules and referral for FNAB. The presence of the taller -than-wide shape, decreased elasticity, microcalcifications, irregular margins, or intranodular blood flow on color Doppler examination strongly increases the risk of malignancy. If the lesions have at least 1 of those features, FNAB should be considered. However, ultrasound markers of malignancy should always be interpreted with caution because none of them reliably differentiates malignant from benign nodules.
